Cargando…
New frontiers for management of hyperkalaemia: the emergence of novel agents
Hyperkalaemia is a common electrolyte abnormality, associated with higher risk of morbid events, and increasing in prevalence—in part, due to increasing rates of comorbidities such as heart failure, chronic kidney disease, diabetes mellitus, and the use of renin-angiotensin-aldosterone system inhibi...
Autores principales: | Nassif, Michael E, Kosiborod, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392414/ https://www.ncbi.nlm.nih.gov/pubmed/30837803 http://dx.doi.org/10.1093/eurheartj/suy036 |
Ejemplares similares
-
Management of hyperkalaemia in adults.
por: McVeigh, G.
Publicado: (2005) -
Current treatment and unmet needs of hyperkalaemia in the emergency department
por: Rafique, Zubaid, et al.
Publicado: (2019) -
New treatments for hyperkalaemia: clinical use in cardiology
por: Vijayakumar, Shilpa, et al.
Publicado: (2019) -
Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…
por: Carrero, Juan Jesus, et al.
Publicado: (2023) -
Hyperkalaemia in Heart Failure
por: Ismail, Umar, et al.
Publicado: (2021)